Keeping Track: US FDA Clears Another CAR-T And Another Novel ADHD Drug; Submissions Blossom

 
• By Bridget Silverman

The latest news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Keeping Track Feature image
Abecma is only the second CBER original approval so far this year.

More from Approvals

More from Product Reviews